Yi Zhang

9PUBLICATIONS
29CO-AUTHORS
Molecular targetsBehavioural epidemiologyMedical bacteriologyCardiology (incl. cardiovascular diseases)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jun 17, 2026
CELF2 is a tumor suppressor that modulates SLC7A11 and promotes ferroptosis in stomach adenocarcinoma.

|Feb 06, 2026
The Aldehyde Dehydrogenase 2 rs671 Variant Enhances Platelet Activation and Arterial Thrombosis.

Song Sun, Xuan Zhang, Hongwei Yue

|Jan 08, 2026
Clinical effect of in-house rapid diagnostic process on patients with bloodstream infections due to carbapenem-resistant bacteria or methicillin-resistant Staphylococcus aureus: a prospective cohort study.

Hongwei Pan, Xiaoyu Zhang, Yiwen Gao

|Apr 09, 2025
Functional study of Bergeyella cardium KP-43 subfamily peptidases as putative T9SS cargo.

Tian Li, Yiwen Gao, Xiaoyue Zhang

|Dec 12, 2023
A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signaling.

Nannan Ning, Ziqi Shang, Zhiping Liu

|Aug 11, 2023
CircHIPK3 contributes to cisplatin resistance in gastric cancer by blocking autophagy-dependent ferroptosis.

Ziqi Shang, Zhengdong Luo, Yifeng Wang

Pageof 2

Frequent Collaborators

2 joint publications

Ziqi Shang

2 joint publications

Hongwei Pan

1 joint publications

Yiwei Xin

1 joint publications

Nannan Ning